Sunao Manabe President and CEO Antoine Yver, MD, MSc Executive VP & Global Head, Oncology R&D PLAY LIST from the beginning R&D Day 2020 @ @ @ @ @ @ Delivering the science patients deserve @ 1 Our scientific and competitiveenvironment @ @ @ @ @ 2 Our clinical-stage DXd ADCs ・DS-8201/trastuzumab deruxtecan(T-DXd) @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ ・DS-1062/datopotamabderuxtecan(Dato-DXd) @ @ @ @ @ @ ・U3-1402/patritumabderuxtecan(HER3-DXd) @ @ @ @ @ @ @ @ @ @ ・Alpha: DS-7300 (B7-H3), DS-6157 (GPR20), DS-6000 (CDH6), DS-3939 (TA-MUC1) @ @ 3 Our transformation towards being abiologics & multi-modality Company @ @ @ @ @ Q&A Consecutive interpretation:Japanese→English Q&A 1 Q&A 2 Q&A 3 Q&A 4 Q&A 5 Q&A 6 Q&A 7 Back Next